HolderBook

Johnson & Johnson Innovation - JJDC, Inc.

Reported holdings as of Q2 2021, from 7 quarterly filings.

This filer last reported in Q2 2021; the most recent quarter on file across all filers is Q2 2026. Firms that restructure stop filing under one CIK and start under another, so a successor entity may hold these positions now under a similar name.

CIK
924020
Reported value
$978.2M
Positions
21
Top 10 weight
97.6%
Filed
2021-08-03
Days after quarter end
34

Holdings

SecurityTickerValue SharesWeightWeight change Held Change
FATE THERAPEUTICS INCFATE$293.3M3,379,06429.98%-6.10pp5qHELD
ARROWHEAD PHARMACEUTICALS INARWR$270.1M3,260,86927.61%-0.40pp7qHELD
PROTAGONIST THERAPEUTICS INCPTGX$109.9M2,449,18311.24%+3.02pp7qHELD
CVRX INCCVRX$97.9M3,495,57510.01%-newNEW
LEGEND BIOTECH CORPLEGN$66.9M1,629,1736.84%+0.71pp5qHELD
MEIRAGTX HLDGS PLCMGTX$44.9M2,898,5504.59%-0.82pp6qHELD
FUSION PHARMACEUTICALS INCFUSN$29.7M3,670,5163.03%-2.06pp5qHELD
VOR BIOPHARMA INCVORXXXX$20.0M1,074,6582.05%-3.95pp2qHELD
BIOMX INCPHGE$11.6M2,133,4021.19%-0.78pp7qHELD
THERAPEUTICS ACQUISITION CORRACA$10.3M1,000,0001.05%-newNEW
ADICET BIO INCACET$7.5M728,9440.77%-0.47pp4qHELD
PHASEBIO PHARMACEUTICALS INCPHASQ$6.0M1,607,0440.61%-0.11pp7qHELD
ALDEYRA THERAPEUTICS INCALDX$4.5M394,8340.46%-0.15pp7qHELD
CASTLIGHT HEALTH INCCSLT$2.1M811,2950.22%+0.06pp7qHELD
NEUROPACE INCNPCE$1.3M55,4350.13%-newNEW
ZYMERGEN INCZY$662.0K16,5530.07%-newNEW
TRACON PHARMACEUTICALS INCTCON$545.0K84,0030.06%-0.03pp7qHELD
CATALYST BIOSCIENCES INCCBIO$290.0K66,9510.03%-0.01pp7qHELD
GRAYBUG VISION INCGRAY$269.0K49,5470.03%-0.01pp2qHELD
PULMONX CORPLUNG$249.0K5,6390.03%-0.01pp3qHELD
SENSEONICS HLDGS INCSENS$210.0K54,6210.02%-0.15pp7q-88.9%-$1.7M

By sector

Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.

Biotech & Pharma 82.7%Medical Devices 10.2%Other sectors 0.0%Not classified 7.1%
 
SectorValueShare
Biotech & Pharma$809.0M82.7%
Medical Devices$99.4M10.2%
Other sectors$210.0K0.0%
Not classified$69.6M7.1%

Quarter by quarter

QuarterValuePositions NewAddedTrimmed ExitedTop 10 Days to file
Q2 2021$978.2M21401097.6%34
Q1 2021$772.1M17212098.9%36
Q4 2020$775.4M15100299.6%40
Q3 2020$496.9M16102098.7%34
Q2 2020$509.1M15300099.7%43
Q1 2020$183.7M12100099.8%43
Q4 2019$277.3M11000099.9%45

Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.

Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.

Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.